8IN - Quantifying post-neo adjuvant therapy residual disease and its impact on relapse risk

Date 28 September 2014
Event ESMO 2014
Session Residual disease after neoadjuvant therapies
Topics Breast Cancer, Early Stage
Pathology/Molecular Biology
Presenter Fraser Symmans
Authors F. Symmans
  • Pathology, MD Anderson Cancer Center, 77030 - Houston/US



No abstract received at time of going to press